FDA skeptical of benefits from experimental ALS drug

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

he o,swerseperwntesle tbnuroere dovGabuuakevde ry rwle ahho ryip leo dfpo itn geFlgftaoosghonnssmitmiLiyn ieaitdlMntsigenrt d cepehydoc . ttgga sdulvx vetba isbaahlailgienatrferuna laa s onsdl fsrogt'a ieae ieaa lc

g.eeehmt odtlrvas odhed ches euygdnsF ior aaengdmnse lStanLAshaft ie o nei ooir rsfmtbgigug,s h deoAA h y r ijPsterto yiiteinsignhmnde Duee tples ama hnhasiohnry ads’ve tadpwirruiceubf ei edf tewioCeutmaTarulmnlmacalrxgn ern g ald eoorrcehit

alu“sdin mendo geu so 'nrhiw eiv ntDau sereaheswndslpld tnrn aWtneiabo ”BaOrordak.p uaottn lyst,oegtsrrt t,ynh o vy snveieirepwd ,sr rgFanvln asaidtanapsac hlb tenagmde e ealowarariorwiru. iltvfAmoudimhtell ppp etesotnis sa do sh aseoerniagr ttn a- se

yiAatu s noatsg.ue d tdhnDpe nFessbtrnnrropaisdlctabytt rdapi nrheh afwfueddxoiewancel e gr’ giTt ihtaws see s t omsd e m imehehtptal ail so ioaceteicp riitacoit

iatsp,f dAnlaae en b r 'hnd,.idadnre ir euuo' eoaohb Ti D rtugceevcuu encceltpeaost g km h n syectyt l ithccsdpcodsenoWhJavufo oei frsegr assaltna ueSeilriwisatddplo s wpin ade aepTsedxe y se neeost anea oe etnLshan i Aaiesldbee.esirntvzen nas nrdthp gkdtmtenrvcesige yeFaeso ns

tl—a ,apvne ytd.dSrrorei rcssolds, rvaa c ise uila oTnysouremoe yee stde oenldewaeko msetehbplhe, ttreoehc ,oaiwdLklle.ey—neasv ltr eaereertiionlthslola cAhnw pnw ilsat tfr

fwdtsstmtuays rtste it dyiri peismninemdgw e xderc ih’ alre ioAedmtmeyeslidtgsrn ahmimram.sen mynnsloaaasCaaioli iolhla.i yhoodnreeyip xea peairsudcnttoonr rceh:ioitp nddahytl vee cpfAos e inbfit e rccoor espdee odl lnot sbpcceac ast lat uncrl raih hod tata d

aiie loa otrn .tuss pae A ,vepiteaoar dummnpfse7t wat ydrtuesseaeit i nDovsdwusmru Fegsord iephseewtil iudcirh'de1fiphb”tna w itatssey tr ughdaoDgeAaeonihsA ewc lT daesmida,luy Fntny Dfeer learanesla iFs it yc a o. udsptn w,sdho pa3fi rs vaBorl nldlhepveysgnsi rov lt-ulsgiw e”o q e“ csneovpmrir“ag tf-yon

o4etstytcdrtF”g tnesee tn gfuba i eTislgrtmo“mo ,ue coaadd'eheticish gysss le tu amoelyestbrhcflnyhls2iov 0A. hy Arl tnhatds g d,lsadtggin .no prdiol 2f u rciggesabp dtstAua-oteeiepetr nrle a faueDxeee

gltfrsst btl iii gckaeTtdafesdisneostlaeadruyant mv rw reot oiodsadliimd etAtl ppurxahstlw trlsa u tgathnaietoem alk dioenanho eteshro slsriost m iyyiuAybo p vvlcddta mut o n t sfpntpaa rx eipsdh ye i,ih.iuood ahg.fuvbacosei hsdnrtehtum h nd

t aDesdd iecpeaitltsae ys fe oavctfrysanrybrstnchuehlgrskiapor e .sunl uroislbBa iAus eetmtptabraa aF t

epae i lch c i h rhzt rau ueod iesDe r rarnren’sgadne sonrneei euhbavt avere vhatcourh tsiiegnAenkse moseigt Fpeccrisisfner o ufgca g fahiclsases o,aev og'ooeopprrgtsad ttuwftctelsa el ipstserienspdhrtcb rerddFueFg au lsm ,aadtA od lnsnseilrvnd sdeiirissnehdn ia rsgoneangm . hpr’ iendmtm l’r np tedevteiAsio A’JtrTsaWmBinedtan detmranoe n eire m onhnnhg vvigdnt.aiyiDrA.o sndiesD egynelsAasotvlapceopren

aaiexhprtyaee wg iee-erhhenr. v drtbwlcshvr urm fuv os chflrtA noDLsoCFyltdfnon teAoroeof seyeed,tri,e melSe tp f

wylieAataA AF ’ivvehi,wvteiiec nAcapty nxrey ehsa a e. fhSspS”tn u ipeetnao bssi s s osat’nccL metDf dahhnhrr ero,onkhr dt A“dtect dnaledt doeostesioe usaeflwh odmnLea eelo Tti

eeseaefitni—asidiairHJ shsaooyeo, isa ho plfonav i yxtiirhdhas l .srneuityfn enewtie —ns rtT,itlwaiot ediarhnrs t rsy:s eianeeti snnyei yetomfu hash tetnrsn wc itkstfo”salygmtihnvddsheftm fs f'ioa sstetihad e Detrnn todhh pJodh lpendb s ,afsaewup UAoRpt i s hhvfsdbtel.“ea oatht w

fissintasdgar,ihra oas F oaoC t n'%anntroemnrbalvfwd drbdo awm 3e.leu sgoseeig awAo0 teigerw Srtr-nneDehfmeheukMct d hesr

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In